Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Controlled release other

Since desorption depends only on the outer barrier layers, multiple lamination offers no advantage in controlled release other than perhaps a safety factor. That is, damage to a single laminate might produce catastrophic dumping, while damage to the outer layer of a multilaminate would only result in a minor disruption of the release. Provided vesicles do not fuse or burst, liposomes and unilamellar vesicles should have identical release properties. [Pg.40]

Cosmetics and Pharmaceuticals. The main use of hexadecanol (cetyl alcohol) is in cosmetics (qv) and pharmaceuticals (qv), where it and octadecanol (stearyl alcohol) are used extensively as emoUient additives and as bases for creams, Hpsticks, ointments, and suppositories. Octadecenol (oleyl alcohol) is also widely used (47), as are the nonlinear alcohols. The compatibiHty of heavy cut alcohols and other cosmetic materials or active dmg agents, their mildness, skin feel, and low toxicity have made them the preferred materials for these appHcations. Higher alcohols and their derivatives are used in conditioning shampoos, in other personal care products, and in ingested materials such as vitamins (qv) and sustained release tablets (see Controlled RELEASE technology). [Pg.449]

In open fibers the fiber wall may be a permselective membrane, and uses include dialysis, ultrafiltration, reverse osmosis, Dorman exchange (dialysis), osmotic pumping, pervaporation, gaseous separation, and stream filtration. Alternatively, the fiber wall may act as a catalytic reactor and immobilization of catalyst and enzyme in the wall entity may occur. Loaded fibers are used as sorbents, and in ion exchange and controlled release. Special uses of hoUow fibers include tissue-culture growth, heat exchangers, and others. [Pg.146]

The rationale for the development of such fibers is demonstrated by their appHcation in the medical field, notably hemoperfusion, where cartridges loaded with activated charcoal-filled hoUow fiber contact blood. Low molecular weight body wastes diffuse through the fiber walls and are absorbed in the fiber core. In such processes, the blood does not contact the active sorbent direcdy, but faces the nontoxic, blood compatible membrane (see Controlled RELEASE TECHNOLOGY, pharmaceutical). Other uses include waste industrial appHcations as general as chromates and phosphates and as specific as radioactive/nuclear materials. [Pg.155]

Layered tablets are also used for a prolonged or sustained therapeutic effect. In this case, one layer disintegrates and dissolves rapidly to provide the initial dosing, whereas the other is designed for controlled release. [Pg.229]

Polyethers such as monensin, lasalocid, salinomycin, and narasin are sold in many countries in crystalline or highly purified forms for incorporation into feeds or sustained-release bolus devices (see Controlled-RELEASE technology). There are also mycelial or biomass products, especially in the United States. The mycelial products are generally prepared by separation of the mycelium and then drying by azeotropic evaporation, fluid-bed driers, continuous tray driers, flash driers, and other types of commercial driers (163). In countries allowing biomass products, crystalline polyethers may be added to increase the potency of the product. [Pg.171]

High nitrogen content distinguishes it from other controlled release nitrogen sources. [Pg.133]

Implantable controlled release dmg deUvery systems, including Norplant and other contraceptive steroids ia siUcone-based devices, have been reviewed (91,92). [Pg.228]

There are various ways in which CMEs can benefit analytical applications. These include acceleration of electron-transfer reactions, preferential accumulation, or selective membrane permeation. Such steps can impart higher selectivity, sensitivity, or stability to electrochemical devices. These analytical applications and improvements have been extensively reviewed (35-37). Many other important applications, including electrochromic display devices, controlled release of drugs, electrosynthesis, and corrosion protection, should also benefit from the rational design of electrode surfaces. [Pg.118]

A current area of interest is the use of AB cements as devices for the controlled release of biologically active species (Allen et al, 1984). AB cements can be formulated to be degradable and to release bioactive elements when placed in appropriate environments. These elements can be incorporated into the cement matrix as either the cation or the anion cement former. Special copper/cobalt phosphates/selenates have been prepared which, when placed as boluses in the rumens of cattle and sheep, have the ability to decompose and release the essential trace elements copper, cobalt and selenium in a sustained fashion over many months (Chapter 6). Although practical examples are confined to phosphate cements, others are known which are based on a variety of anions polyacrylate (Chapter 5), oxychlorides and oxysulphates (Chapter 7) and a variety of organic chelating anions (Chapter 9). The number of cements available for this purpose is very great. [Pg.3]

There are a host of other, non-catalytic applications of TUD-1 possible, for example in the area of sorption. In fact, the successful application of TUD-1 as a controlled release drag delivery system was recently demonstrated (33). [Pg.377]

This topic is the subject of Chapter 15, but some of the materials that are used in these systems have other uses as well (Table 5). Materials used to modify dissolution can be incorporated in the formulation on either a dry or wet basis. Table 11 lists some of the more commonly used controlled release excipients. [Pg.308]

Before treating the various classes of sustained- and controlled-release drug-delivery systems in this chapter, it is appropriate to note that drug delivery may be incorporated in other chapters where the various classes of drug products and routes of administration are discussed. In addition, the reader is referred to Chapter 14 on target-oriented drug-delivery systems. [Pg.505]


See other pages where Controlled release other is mentioned: [Pg.242]    [Pg.93]    [Pg.231]    [Pg.13]    [Pg.186]    [Pg.483]    [Pg.117]    [Pg.134]    [Pg.134]    [Pg.140]    [Pg.141]    [Pg.33]    [Pg.338]    [Pg.795]    [Pg.238]    [Pg.640]    [Pg.143]    [Pg.58]    [Pg.225]    [Pg.1]    [Pg.2]    [Pg.28]    [Pg.31]    [Pg.231]    [Pg.352]    [Pg.18]    [Pg.100]    [Pg.122]    [Pg.99]    [Pg.41]    [Pg.29]    [Pg.297]    [Pg.297]    [Pg.326]    [Pg.504]    [Pg.531]    [Pg.715]   
See also in sourсe #XX -- [ Pg.108 , Pg.109 ]




SEARCH



Controlled release

© 2024 chempedia.info